Real-time polymerase chain reaction analysis of MDM2 and CDK4expression using total RNA from core-needle biopsies is useful for diagnosing adipocytic tumors
Authors:
- Taro SasakiTSTaro Sasaki
- Akira OgoseAOAkira Ogose
- Hiroyuki KawashimaHKHiroyuki Kawashima
- Tetsuo HottaTHTetsuo Hotta
- Hiroshi HatanoHHHiroshi Hatano
- Takashi AriizumiTATakashi Ariizumi
- Hajime UmezuHUHajime Umezu
- Riuko OhashiRiuko Ohashi
- Tsuyoshi TohyamaTTTsuyoshi Tohyama
- Naohito TanabeNTNaohito Tanabe
- Naoto EndoNENaoto Endo
Open Access
- 26 June 2014
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 468
Abstract
Diagnosing adipocytic tumors can be challenging because it is often difficult to morphologically distinguish between benign, intermediate and malignant adipocytic tumors, and other sarcomas that are histologically similar. Recently, a number of tumor-specific chromosome translocations and associated fusion genes have been identified in adipocytic tumors and atypical lipomatous tumors/well-differentiated liposarcomas (ALT/WDL), which have a supernumerary ring and/or giant chromosome marker with amplified sequences of the MDM2 and CDK4 genes. The purpose of this study was to investigate whether quantitative real-time polymerase chain reaction (PCR) could be used to amplify MDM2 and CDK4 from total RNA samples obtained from core-needle biopsy sections for the diagnosis of ALT/WDL. A series of lipoma (n = 124) and ALT/WDL (n = 44) cases were analyzed for cytogenetic analysis and lipoma fusion genes, as well as for MDM2 and CDK4 expression by real-time PCR. Moreover, the expression of MDM2 and CDK4 in whole tissue sections was compared with that in core-needle biopsy sections of the same tumor in order to determine whether real-time PCR could be used to distinguish ALT/WDL from lipoma at the preoperative stage. In whole tissue sections, the medians for MDM2 and CDK4 expression in ALT/WDL were higher than those in the lipomas (P < 0.05). Moreover, karyotype subdivisions with rings and/or giant chromosomes had higher MDM2 and CDK4 expression levels compared to karyotypes with 12q13-15 rearrangements, other abnormal karyotypes, and normal karyotypes (P < 0.05). On the other hand, MDM2 and CDK4 expression levels in core-needle biopsy sections were similar to those in whole-tissue sections (MDM2: P = 0.6, CDK4: P = 0.8, Wilcoxon signed-rank test). Quantitative real-time PCR of total RNA can be used to evaluate the MDM2 and CDK4 expression levels in core-needle biopsies and may be useful for distinguishing ALT/WDL from adipocytic tumors. Thus, total RNA from core-needle biopsy sections may have potential as a routine diagnostic tool for other tumors where gene overexpression is a feature of the tumor.Keywords
This publication has 22 references indexed in Scilit:
- Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS‐1Pathology International, 2011
- Contributions of Cytogenetics and Molecular Cytogenetics to the Diagnosis of Adipocytic TumorsBioMed Research International, 2011
- Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumoursJournal of Clinical Pathology, 2009
- Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasmsLaboratory Investigation, 2008
- Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotypeGenes, Chromosomes and Cancer, 2007
- Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipomaCancer Genetics and Cytogenetics, 2004
- Evaluation of MDM2 and CDK4 amplification by real‐time PCR on paraffin wax‐embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well‐differentiated liposarcomasThe Journal of Pathology, 2003
- Liposarcoma: New entities and evolving conceptsAnnals of Diagnostic Pathology, 2000
- LPP,the Preferred Fusion Partner Gene ofHMGICin Lipomas, Is a Novel Member of the LIM Protein Gene FamilyGenomics, 1996
- MDM2 gene amplification in bone and soft‐tissue tumors: Association with tumor progression in differentiated adipose‐tissue tumorsInternational Journal of Cancer, 1995